About Us
Company Overview:
Salvaxis is built on a foundation of industry expertise and regulatory excellence. With decades of combined experience, our team supports pharmaceutical companies in navigating complex regulatory landscapes while ensuring the highest standards of quality, safety, and operational efficiency.
Why Choose Salvaxis?
Proven success in guiding clients through FDA, EMA, and WHO regulatory requirements.
A hands-on, results-driven approach tailored to client-specific needs.
Expertise across various pharmaceutical and biotech sectors, from startup laboratories to established manufacturers.
Leadership Team
Nancy Lake
Chief Executive Officer
Nancy Lake is a seasoned pharmaceutical executive with over 30 years of experience leading New Drug Application (NDA) and Abbreviated New Drug Application (ANDA) development. As CEO, she brings a rare combination of deep regulatory expertise, operational leadership, and strategic vision to every project. Throughout her career, Nancy has successfully guided numerous drug products from concept to market, working closely with the FDA and global regulatory agencies to ensure full compliance and streamlined approvals.
Her leadership style is rooted in precision, integrity, and a passion for advancing healthcare through innovation. Nancy’s extensive knowledge of drug development, coupled with her ability to lead cross-functional teams, has positioned her as a trusted authority in the pharmaceutical industry.
Under her guidance, the company continues to build a legacy of scientific excellence, regulatory success, and sustainable growth.
Jonathan Iriglio
Chief Operating Officer
Jonathan Iriglio is an accomplished operations leader with over 20 years of experience driving performance, efficiency, and quality in the pharmaceutical industry. As Chief Operating Officer, Jonathan brings a deep expertise in Lean Six Sigma, operational excellence, and regulatory pathways including ANDA and NDA development.
His background in Good Manufacturing Practices (cGMP) and large-scale production management has made him a trusted force in aligning day-to-day operations with long-term strategic goals. Known for building high-performance teams and streamlining complex processes, Jonathan ensures that operational systems not only meet industry standards—but exceed them.
With a commitment to quality, compliance, and continuous improvement, Jonathan plays a vital role in shaping the company’s success from the ground up.
Joseph Myers
Chief Scientific Officer
Joseph Myers brings over 40 years of pharmaceutical industry experience, specializing in regulatory science, formulation, and drug development. As Chief Scientific Officer, he serves as the scientific backbone of the organization, with a deep-rooted expertise in FDA regulations for product approval across both NDA and ANDA pathways.
Joseph’s career is defined by his strong command of formulation and development strategies, guiding products from early-stage research through successful regulatory submission and commercialization. His practical, hands-on approach combined with a strategic mindset ensures that every product is developed with precision, compliance, and patient outcomes in mind.
Respected for his integrity, depth of knowledge, and commitment to scientific excellence, Joseph plays a pivotal role in advancing the company’s mission of delivering high-quality, compliant pharmaceutical solutions to the market.
Bryan Maxwell
Chief Financial Officer
Bryan Maxwell is a seasoned financial executive with 15 years of experience driving fiscal strategy, financial planning, and operational efficiency across the financial and life sciences sectors. As Chief Financial Officer, Bryan leads with a strong command of corporate finance, capital structuring, risk management, and long-range budgeting—ensuring the financial health and scalability of the organization.
Throughout his career, Bryan has successfully navigated complex regulatory environments, supported multi-million-dollar budgets, and implemented financial systems that drive transparency and growth. His analytical mindset and strategic foresight have been instrumental in aligning financial operations with broader business goals.
With a proven track record of maximizing value, improving margins, and building strong investor relationships, Bryan plays a critical role in supporting sustainable growth and long-term success. His leadership brings both financial discipline and forward-thinking insight to the executive team.
Industries We Serve:
Pharmaceutical Manufacturers
Ensuring regulatory compliance for large-scale operations.
Startup Laboratories
Providing strategic guidance for emerging pharmaceutical ventures.
Contract Manufacturing Organizations (CMOs)
Assisting with audits, quality systems, and operational compliance.